Like the overall market, the second quarter for the Life Science Instrument industry shows both current economic strength but also uncertainty for the future.
IBO looks at the role that foreign and domestic lab instrument brands play in China
Company annual revenues more than double
NHS launches national genomic test program
Pharma and CROs to drive MS-IMS growth
Decision affects Bio-Rad patents
Oil companies increase investments in natural gas
PhRMA members support biotech startups through corporate VC funds
GCC countries increase funding in infrastructure, but need to improve research ecosystems
New OECD report examines how public research policies are governed
Pay Invoice
Latest Blogs
-
Paving The Way for Change: 10x Genomics Announces Corporate Strategies for a Fruitful 2025
February 26, 2025 1:05 pm
-
SLAS2025: Lab Automation and More
January 23, 2025 4:00 pm
-
LAUDA: Temperature Control Innovation
December 10, 2024 4:11 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
